Incomplete CD4 T cell recovery in HIV-1 infection after 12 months of highly active antiretroviral therapy is associated with ongoing increased CD4 T cell activation and turnover
- PMID: 12794543
- DOI: 10.1097/00126334-200306010-00002
Incomplete CD4 T cell recovery in HIV-1 infection after 12 months of highly active antiretroviral therapy is associated with ongoing increased CD4 T cell activation and turnover
Abstract
To evaluate the relationship between T cell turnover, immune activation, and CD4 recovery in HIV infection, 32 antiretroviral-naive HIV-1-infected patients were studied before and after initiation of highly active antiretroviral therapy (HAART). Elevated CD4 and CD8 T cell turnover (measured by Ki67) in HIV infection decreased with HAART in blood and lymphoid tissue. Increased peripheral CD4 T cell turnover was strongly associated with immune activation even after viral suppression to less than 50 copies/mL (R = 0.8; p <.001). Increased CD4 T cell turnover correlated strongly with CD4 cell counts both before (R = -0.6; p <.001) and after (R = -0.4; p =.05) HAART. In patients with baseline CD4 cell counts of less than 350/microL, decreases in CD4 T cell turnover with HAART significantly correlated with increases in CD4 cell counts. In addition, persistently elevated levels of CD4 T cell turnover after HAART were associated with incomplete CD4 T cell recovery despite HIV RNA levels of less than 50 copies/mL. These data suggest that immune activation is central to CD4 cell depletion in HIV infection and immune reconstitution with HAART.
Similar articles
-
T-cell division in human immunodeficiency virus (HIV)-1 infection is mainly due to immune activation: a longitudinal analysis in patients before and during highly active antiretroviral therapy (HAART).Blood. 2000 Jan 1;95(1):249-55. Blood. 2000. PMID: 10607709 Clinical Trial.
-
Differential upregulation of CD38 on different T-cell subsets may influence the ability to reconstitute CD4+ T cells under successful highly active antiretroviral therapy.J Acquir Immune Defic Syndr. 2005 Apr 1;38(4):373-81. doi: 10.1097/01.qai.0000153105.42455.c2. J Acquir Immune Defic Syndr. 2005. PMID: 15764953
-
Evaluation of the impact of highly active antiretroviral therapy on immune recovery in antiretroviral naive patients.HIV Med. 2004 Jan;5(1):55-65. doi: 10.1111/j.1468-1293.2004.00186.x. HIV Med. 2004. PMID: 14731171
-
Human immunodeficiency virus and the gastrointestinal immune system: does highly active antiretroviral therapy restore gut immunity?Mucosal Immunol. 2012 Nov;5(6):596-604. doi: 10.1038/mi.2012.82. Epub 2012 Aug 29. Mucosal Immunol. 2012. PMID: 22929559 Review.
-
Incomplete immune recovery in HIV infection: mechanisms, relevance for clinical care, and possible solutions.Clin Dev Immunol. 2012;2012:670957. doi: 10.1155/2012/670957. Epub 2012 Mar 14. Clin Dev Immunol. 2012. PMID: 22474480 Free PMC article. Review.
Cited by
-
Impact of hepatitis C virus coinfection on immune restoration during successful antiretroviral therapy in chronic human immunodeficiency virus type 1 disease.Eur J Clin Microbiol Infect Dis. 2008 Jan;27(1):65-73. doi: 10.1007/s10096-007-0384-3. Eur J Clin Microbiol Infect Dis. 2008. PMID: 17938979
-
Elevated frequencies of highly activated CD4+ T cells in HIV+ patients developing immune reconstitution inflammatory syndrome.Blood. 2010 Nov 11;116(19):3818-27. doi: 10.1182/blood-2010-05-285080. Epub 2010 Jul 26. Blood. 2010. PMID: 20660788 Free PMC article. Clinical Trial.
-
The effect of leflunomide on cycling and activation of T-cells in HIV-1-infected participants.PLoS One. 2010 Aug 3;5(8):e11937. doi: 10.1371/journal.pone.0011937. PLoS One. 2010. PMID: 20689824 Free PMC article. Clinical Trial.
-
Antiretroviral therapy prior to acute viral replication preserves CD4 T cells in the periphery but not in rectal mucosa during acute simian immunodeficiency virus infection.J Virol. 2008 Nov;82(22):11467-71. doi: 10.1128/JVI.01143-08. Epub 2008 Sep 3. J Virol. 2008. PMID: 18768962 Free PMC article.
-
Replication capacity in relation to immunologic and virologic outcomes in HIV-1-infected treatment-naive subjects.J Acquir Immune Defic Syndr. 2009 Mar 1;50(3):250-8. doi: 10.1097/QAI.0b013e3181938faf. J Acquir Immune Defic Syndr. 2009. PMID: 19194319 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials